Rituximab shows potential in patients with primary Sjögren's syndrome

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1496, 2005-01, pp. : 6-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CNS Involvement in Primary Sjögren's Syndrome: Prevalence, Clinical Aspects, Diagnostic Assessment and Therapeutic Approach

By Govoni M. Padovan M. Rizzo N. Trotta F.

CNS Drugs, Vol. 15, Iss. 8, 2001-01 ,pp. : 597-607

Adis International

Access to resources Recommend Favorite

Paclitaxel: Cutaneous lupus erythematosus in patients with Sjögren's syndrome: 2 case reports

Reactions Weekly, Vol. 1, Iss. 1172, 2007-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite

Review of the Pharmacological Properties and Clinical Usefulness of Muscarinic Agonists for Xerostomia in Patients with Sjögren's Syndrome

By Yasuda H. Niki H.

Clinical Drug Investigation, Vol. 22, Iss. 2, 2002-01 ,pp. : 67-73

Adis International

Access to resources Recommend Favorite

Rational Drug Therapy Recommendations for the Treatment of Patients with Sjögren's Syndrome

By Oxholm P.

Drugs, Vol. 56, Iss. 3, 1998-09 ,pp. : 345-353

Adis International

Access to resources Recommend Favorite

Sjögren's Syndrome: Diagnosis and Therapeutic Challenges in the Elderly

By Ng Kristine P. Isenberg David A.

Drugs & Aging, Vol. 25, Iss. 1, 2008-01 ,pp. : 19-33

Adis International

Access to resources Recommend Favorite